Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hay

Showing results (291-300 of 299) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 299 results.
Frontiers in Pharmacology|August 30, 2017
Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in MiceYongchuan Gu, Tony T-A Chang, Jingli Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbitPatricia L Podolin, Brian J Bolognese, James J Foley, et al.
HIV Medicine|July 23, 2015
Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery ratesM E O Perry, G P Taylor, C A Sabin, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 26, 2013
Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseasesMichael Salmon, Mark A Luttmann, James J Foley, et al.
Science Translational Medicine|August 5, 2011
Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethalityDenise A Chan, Patrick D Sutphin, Phuong Nguyen, et al.
The Journal of Clinical Investigation|October 30, 2018
Dynamin impacts homology-directed repair and breast cancer response to chemotherapySophia B Chernikova, Rochelle B Nguyen, Jessica T Truong, et al.
ACS Pharmacology & Translational Science|April 17, 2020
Identification of Small-Molecule Positive Modulators of Calcitonin-like Receptor-Based ReceptorsErica R Hendrikse, Lydia P Liew, Rebekah L Bower, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 26, 2001
Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigsDouglas W P Hay, Giuseppe A M Giardina, Don E Griswold, et al.
Lancet (London, England)|October 19, 2024
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trialAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.
Pageof 30

Showing results (291-300 of 299) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 299 results.
Frontiers in Pharmacology|August 30, 2017
Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in MiceYongchuan Gu, Tony T-A Chang, Jingli Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2002
A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbitPatricia L Podolin, Brian J Bolognese, James J Foley, et al.
HIV Medicine|July 23, 2015
Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery ratesM E O Perry, G P Taylor, C A Sabin, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 26, 2013
Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseasesMichael Salmon, Mark A Luttmann, James J Foley, et al.
Science Translational Medicine|August 5, 2011
Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethalityDenise A Chan, Patrick D Sutphin, Phuong Nguyen, et al.
The Journal of Clinical Investigation|October 30, 2018
Dynamin impacts homology-directed repair and breast cancer response to chemotherapySophia B Chernikova, Rochelle B Nguyen, Jessica T Truong, et al.
ACS Pharmacology & Translational Science|April 17, 2020
Identification of Small-Molecule Positive Modulators of Calcitonin-like Receptor-Based ReceptorsErica R Hendrikse, Lydia P Liew, Rebekah L Bower, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 26, 2001
Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigsDouglas W P Hay, Giuseppe A M Giardina, Don E Griswold, et al.
Lancet (London, England)|October 19, 2024
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trialAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.
Pageof 30